Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide datasetY K Eysbouts, P B Ottevanger, L F A G Massuger, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 9, 2020
Demographics, natural history and treatment outcomes of non-molar gestational choriocarcinoma: a UK population studyP Savage, M Winter, V Parker, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2019
The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasiaM M Frijstein, C A R Lok, D Short, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 4, 2019
Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort studyM M Frijstein, Car Lok, N E van Trommel, et al.
Journal of Medical Genetics|February 28, 2009
Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich regionC M Wang, P H Dixon, S Decordova, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2017
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network settingI Ray-Coquard, AnnaLisa Trama, M J Seckl, et al.
Oncogene|March 23, 2011
An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasisR Lara, F A Mauri, H Taylor, et al.
British Journal of Cancer|October 9, 1998
High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levelsE J Kanfer, D McGuigan, D Samson, et al.
Gynecologic Oncology|November 27, 2018
Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases databaseM M Frijstein, C A R Lok, N E van Trommel, et al.
Nature Communications|June 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.
Pageof 8